<Record>
<Term>Valopicitabine</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Pyrimidine Antagonist</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Antineoplastic Agent/Antimetabolite/Pyrimidine Antagonist/Valopicitabine Dihydrochloride</ClassificationPath>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Antineoplastic Agent/Antimetabolite/Pyrimidine Antagonist/Valopicitabine</ClassificationPath>
<BroaderTerm>Valopicitabine Dihydrochloride</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Antineoplastic Agent</BroaderTerm>
<BroaderTerm>Pyrimidine Antagonist</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Antimetabolite</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Valopicitabine</BroaderTerm>
<Synonym>Valopicitabine Dihydrochloride</Synonym>
<Synonym>NM-283</Synonym>
<Synonym>VALOPICITABINE DIHYDROCHLORIDE</Synonym>
<Synonym>VALOPICITABINE</Synonym>
<Synonym>Valopicitabine</Synonym>
<Source>NCI Thesaurus</Source>
</Record>
